| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 18/12/2024 | 23:15 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 18/12/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 04/12/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 26/11/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 21/11/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 15/11/2024 | 01:16 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 13/11/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 07/11/2024 | 14:36 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 31/10/2024 | 13:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 29/10/2024 | 13:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 24/10/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Celebrates One Year Anniversary of Enhanced Workplace Safety with London-Based Real-Estate Developer, Mount Anvil | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 14/10/2024 | 14:00 | GlobeNewswire Inc. | Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 09/10/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Partners with Spirit Group as Australian Distributor, Expanding Community Impact with Intelligent Fingerprinting Drug Testing Solution | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 01/10/2024 | 14:30 | GlobeNewswire Inc. | GPS Marine Adopts Intelligent Bio Solutions’ Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 27/09/2024 | 23:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 27/09/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 25/09/2024 | 14:30 | GlobeNewswire Inc. | UK’s Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions’ Fingerprint Drug Test to Enhance Workplace Safety | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 19/09/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 18/09/2024 | 22:19 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 18/09/2024 | 15:18 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 11/09/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024 | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 09/09/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-Year | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 05/09/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Inc. Announces Progress Toward Completion of Clinical Study Plan Required for FDA 510(k) Submission | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 03/09/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Inc. Reports 118% Year-Over-Year Growth in Customer Employee Base, Reaching an Estimated Total of 1.4 Million Employees | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 21/08/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Inc. Achieves Major Milestone with Over 1,000 Installed Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024 | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 13/08/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Inc. Highlights Growing Need for Drug Testing Solutions in Key Industries | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 01/08/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 24/07/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi Arabia | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 18/07/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study Success | NASDAQ:INBS | Intelligent Bio Solutions Inc |
| 09/07/2024 | 14:30 | GlobeNewswire Inc. | Intelligent Bio Solutions Strengthens UK Market Position with Addition of Key Manufacturing Accounts | NASDAQ:INBS | Intelligent Bio Solutions Inc |